FDF / DRUG PRODUCTS NUTRACEUTICALS SERVICES in LATAM
The Barretos site specializes in the manufacturing of liquid and solid forms for the pharmaceutical and nutraceutical markets.
About the plant
The Barretos manufacturing site, located in the state of São Paulo, Brazil, is part of the global industrial network of Unither Pharmaceuticals, a contract development and manufacturing organization (CDMO) specializing in liquid pharmaceutical formulations and unit-dose technologies. The site joined the Unither group through the acquisition of the Brazilian pharmaceutical manufacturer Mariol Industrial, reinforcing the company’s presence in South America and expanding its global production capabilities.
The facility provides contract development and manufacturing services for pharmaceutical and consumer healthcare products. It manufactures a wide range of dosage forms including liquid, semi-solid, and solid formulations, supporting both pharmaceutical and over-the-counter (OTC) markets. The Barretos plant is particularly recognized for its expertise in liquid stick-pack technology, an innovative packaging format used for single-dose oral liquid products that improves convenience, portability, and patient compliance.
The site supports pharmaceutical partners throughout the product lifecycle, offering services such as formulation development, technology transfer, manufacturing, packaging, and quality control testing. With modern production facilities and experienced technical teams, the plant contributes to supplying pharmaceutical products to regional and international markets.
As part of Unither’s global manufacturing network spanning Europe, North America, Asia, and South America, the Barretos site plays an important role in delivering high-quality, accessible healthcare solutions while supporting the growing pharmaceutical market in Latin America.
Compliance
- EMA (EU GMP)
- FDA (cGMP)
- ANVISA (Brazil B-GMP)
Activity
- Oral liquids and semisolids, Oral solids / OSD, Bottles, Sachets, Stick packs, Oral solutions, Oral suspensions, Tablets, FDF / DRUG PRODUCTS, NUTRACEUTICALS, SERVICES, Hard capsules, Granules / Pellets, Solutions, Suspensions, Syrups, Bottles: Plastic, Bottles: Glass manufacturing
Features
- Uses: Commercial (Phase IV), Human
- Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day)
- Controlled substance: Lowest potential for abuse
- BSL: N/A
- Therapeutic areas: (A) Digestive tract and metabolism, (M) Musculoskeletal system, (N) Nervous system, (R) Respiratory system
- Markets: FDA (USA), EMA (EU), ANVISA (Brazil)
Batch Size / Reactor
- Medium, Large
Services
- Development services, Manufacturing services, Analytical / QC services, Formulation / Galenic design, Process development, Stability studies design, Stability studies execution, Tech transfer, Pilot plant, Scale-up, Registration batches, Analytical methods development, Analytical methods validation, Release testing of raw materials, Release testing of product, Analytical methods transfer, Identity, Content, Purity / Potency, Impurities, Drug Product – Liquid, Drug Product – Solid, API / Excipient – Liquid, API / Excipient – Solid
Other plants of this company
FDF / DRUG PRODUCTS SERVICES in North America CDMO specializing in sterile unit-dose liquid drug products using Blow-Fill-Seal (BFS) technology for ophthalmic, nasal and inhalation therapies.
FDF / DRUG PRODUCTS SERVICES in Europe Make affordable healthcare solutions that improve and simplify patients lives
FDF / DRUG PRODUCTS SERVICES in APAC The Nanjing site specializes in the development and production of solid and liquid pharmaceutical forms, both sterile and non-sterile.
